Advocacy intelligence hub — real-time data for patient organizations
Assistance Publique - Hôpitaux de Paris
Quoin Pharmaceuticals — PHASE2, PHASE3
BioCryst Pharmaceuticals — PHASE1
Azitra Inc. — PHASE1
Quoin Pharmaceuticals — PHASE2, PHASE3
Quoin Pharmaceuticals — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Tony Andrasfay
Therapeutics, Inc.
Emma Guttman-Yassky, MD, PhD
Mt. Sinai Hospital Department of Dermatology
Amy Paller, MD, MD
Northwestern University Department of Dermatology
📍 CHICAGO, IL
Albert C Yan, MD
Children's Hospital of Philadelphia
📍 PARAMOUNT, CA
Mary Spellman, MD, M.D
Azitra Inc.
📍 SAN FRANCISCO, CA
Maarten de Chateau, MD PhD
Sixera Pharma